Literature DB >> 11968003

Relative effects of VEGF-A and VEGF-C on endothelial cell proliferation, migration and PAF synthesis: Role of neuropilin-1.

Pascal N Bernatchez1, Simon Rollin, Shay Soker, Martin G Sirois.   

Abstract

Vascular endothelial growth factor (VEGF-A) is an inducer of endothelial cell (EC) proliferation, migration, and synthesis of inflammatory agents such as platelet-activating factor (PAF). Recently, neuropilin-1 (NRP-1) has been described as a coreceptor of KDR which potentiates VEGF-A activity. However, the role of NRP-1 in numerous VEGF-A activities remains unclear. To assess the contribution of NRP-1 to VEGF-A mediated EC proliferation, migration, and PAF synthesis, we used porcine aortic EC (PAEC) recombinantly expressing Flt-1, NRP-1, KDR or KDR and NRP-1. Cells were stimulated with VEGF-A, which binds to Flt-1, KDR and NRP-1, and VEGF-C, which binds to KDR only. VEGF-A was 12.4-fold more potent than VEGF-C in inducing KDR phosphorylation in PAEC-KDR. VEGF-A and VEGF-C showed similar potency to mediate PAEC-KDR proliferation, migration, and PAF synthesis. On PAEC-KDR/NRP-1, VEGF-A was 28.6-fold more potent than VEGF-C in inducing KDR phosphorylation and PAEC-KDR/NRP-1 proliferation (1.3-fold), migration (1.7-fold), and PAF synthesis (4.6-fold). These results suggest that cooperative binding of VEGF-A to KDR and NRP-1 enhances KDR phosphorylation and its biological activities. Similar results were obtained with bovine aortic EC that endogenously express both KDR and NRP-1 receptors. In contrast, stimulation of PAEC-Flt-1 and PAEC-NRP-1 with VEGF-A or VEGF-C did not induce proliferation, migration, or PAF synthesis. In conclusion, the presence of NRP-1 on EC preferentially increases KDR activation by VEGF-A as well as KDR-mediated biological activities, and may elicit novel intracellular events. On the other hand, VEGF-A and VEGF-C have equipotent biological activities on EC in absence of NRP-1. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11968003     DOI: 10.1002/jcb.10155

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  24 in total

1.  Functional characterization and expression profiling of human induced pluripotent stem cell- and embryonic stem cell-derived endothelial cells.

Authors:  Zongjin Li; Shijun Hu; Zhumur Ghosh; Zhongchao Han; Joseph C Wu
Journal:  Stem Cells Dev       Date:  2011-02-28       Impact factor: 3.272

2.  Effect of tissue specificity on the performance of extracellular matrix in improving endothelialization of cardiovascular implants.

Authors:  Qiufen Tu; Zhilu Yang; Ying Zhu; Kaiqin Xiong; Manfred F Maitz; Jin Wang; Yuancong Zhao; Nan Huang; Jian Jin; Yuechang Lei
Journal:  Tissue Eng Part A       Date:  2012-10-04       Impact factor: 3.845

3.  Anti-neuropilin-1 (MNRP1685A): unexpected pharmacokinetic differences across species, from preclinical models to humans.

Authors:  Yan Xin; Shuang Bai; Lisa A Damico-Beyer; Denise Jin; Wei-Ching Liang; Yan Wu; Frank-Peter Theil; Amita Joshi; Yanmei Lu; John Lowe; Mauricio Maia; Rainer K Brachmann; Hong Xiang
Journal:  Pharm Res       Date:  2012-06-16       Impact factor: 4.200

4.  Acute cytotoxicity and increased vascular endothelial growth factor after in vitro nitrogen mustard vapor exposure.

Authors:  Matthew D McGraw; So-Young Kim; Carl W White; Livia A Veress
Journal:  Ann N Y Acad Sci       Date:  2020-05-14       Impact factor: 5.691

5.  Thrombospondin-1 inhibits VEGF levels in the ovary directly by binding and internalization via the low density lipoprotein receptor-related protein-1 (LRP-1).

Authors:  James Greenaway; Jack Lawler; Roger Moorehead; Paul Bornstein; Jonathan Lamarre; Jim Petrik
Journal:  J Cell Physiol       Date:  2007-03       Impact factor: 6.384

Review 6.  [Molecular biology approach to explain lymphatic metastasis].

Authors:  F Vom Dorp; B Wullich; E Gulbins; A Eisenhardt
Journal:  Urologe A       Date:  2005-06       Impact factor: 0.639

7.  Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth.

Authors:  Romulo J C Albuquerque; Takahiko Hayashi; Won Gil Cho; Mark E Kleinman; Sami Dridi; Atsunobu Takeda; Judit Z Baffi; Kiyoshi Yamada; Hiroki Kaneko; Martha G Green; Joe Chappell; Jörg Wilting; Herbert A Weich; Satoru Yamagami; Shiro Amano; Nobuhisa Mizuki; Jonathan S Alexander; Martha L Peterson; Rolf A Brekken; Masanori Hirashima; Seema Capoor; Tomohiko Usui; Balamurali K Ambati; Jayakrishna Ambati
Journal:  Nat Med       Date:  2009-08-09       Impact factor: 53.440

8.  Semaphorin 3B inhibits the phosphatidylinositol 3-kinase/Akt pathway through neuropilin-1 in lung and breast cancer cells.

Authors:  Emely Castro-Rivera; Sophia Ran; Rolf A Brekken; John D Minna
Journal:  Cancer Res       Date:  2008-10-15       Impact factor: 12.701

9.  High levels of vascular endothelial growth factor and its receptors (VEGFR-1, VEGFR-2, neuropilin-1) are associated with worse outcome in breast cancer.

Authors:  Sriparna Ghosh; Catherine A W Sullivan; Maciej P Zerkowski; Annette M Molinaro; David L Rimm; Robert L Camp; Gina G Chung
Journal:  Hum Pathol       Date:  2008-08-20       Impact factor: 3.466

10.  Neuropilin-1 antagonism in human carcinoma cells inhibits migration and enhances chemosensitivity.

Authors:  H Jia; L Cheng; M Tickner; A Bagherzadeh; D Selwood; I Zachary
Journal:  Br J Cancer       Date:  2010-01-19       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.